Literature DB >> 3566250

Susceptibility of Mobiluncus species to 23 antimicrobial agents and 15 other compounds.

C A Spiegel.   

Abstract

The susceptibility of 12 strains of Mobiluncus curtisii and 10 strains of M. mulieris to 23 antimicrobial agents and 15 other compounds was determined. All strains were susceptible to chloramphenicol, clindamycin, rifampin, tobramycin, vancomycin, virginiamycin, and all beta-lactam antibiotics tested, including imipenem. One strain of M. mulieris was resistant to erythromycin and josamycin. All were resistant to colistin, cycloserine, nalidixic acid, and neomycin. Tetracycline had variable activity. All M. curtisii strains were resistant to metronidazole and its hydroxy metabolite. Of 10 M. mulieris strains, 5 were resistant to metronidazole and 2 were resistant to its hydroxy metabolite. All 12 M. curtisii and 1 of 10 M. mulieris strains were resistant to tinidazole. M. curtisii and M. mulieris produced two mutually exclusive clusters of MICs when tested against ampicillin, cefoxitin, cephalothin, moxalactam, alizarin red, Evans blue, and sodium fluoride. Gardnerella vaginalis was more susceptible to Nile blue A than was either M. curtisii or M. mulieris. Clindamycin and imipenem may be useful agents in the therapy of metronidazole-resistant bacterial vaginosis. Metronidazole, tinidazole, and Nile blue A may be of value in the development of a selective agar for Mobiluncus species.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3566250      PMCID: PMC174700          DOI: 10.1128/AAC.31.2.249

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Identification of Gardnerella (Haemophilus) vaginalis.

Authors:  P Piot; E Van Dyck; P A Totten; K K Holmes
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

2.  Antimicrobial susceptibility of comma-shaped bacteria isolated from the vagina.

Authors:  A Skarin; E Holst; P A Mårdh
Journal:  Scand J Infect Dis Suppl       Date:  1983

3.  Antibiotic susceptibility of Haemophilus vaginalis (Corynebacterium vaginale) to 21 antibiotics.

Authors:  L R McCarthy; P A Mickelsen; E G Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

4.  Clinical and microbiological characterization of patients with nonspecific vaginosis associated with motile, curved anaerobic rods.

Authors:  J L Thomason; P C Schreckenberger; W N Spellacy; L J Riff; L J LeBeau
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

5.  Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy.

Authors:  C A Spiegel; D A Eschenbach; R Amsel; K K Holmes
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

6.  Selective differential human blood bilayer media for isolation of Gardnerella (Haemophilus) vaginalis.

Authors:  P A Totten; R Amsel; J Hale; P Piot; K K Holmes
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

7.  Characteristics of motile curved rods in vaginal secretions.

Authors:  M S Sprott; H R Ingham; R S Pattman; R L Eisenstadt; G R Short; H K Narang; P R Sisson; J B Selkon
Journal:  J Med Microbiol       Date:  1983-05       Impact factor: 2.472

8.  Ineffectiveness of erythromycin for treatment of Haemophilus vaginalis-associated vaginitis: possible relationship to acidity of vaginal secretions.

Authors:  M A Durfee; P S Forsyth; J A Hale; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

9.  Relative susceptibilities of Gardnerella vaginalis (Haemophilus vaginalis), Neisseria gonorrhoeae, and Bacteroides fragilis to Metronidazole and its two major metabolites.

Authors:  E D Ralph; Y E Amatnieks
Journal:  Sex Transm Dis       Date:  1980 Oct-Dec       Impact factor: 2.830

  9 in total
  13 in total

Review 1.  Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.

Authors:  Ronald F Lamont; Chia-Ling Nhan-Chang; Jack D Sobel; Kimberly Workowski; Agustin Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2011-04-02       Impact factor: 8.661

Review 2.  Newly recovered and delineated microbial species of the human genital tract.

Authors:  R Hammann
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

Review 3.  Bacterial vaginosis.

Authors:  C A Spiegel
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

4.  Association of Mobiluncus curtisii with recurrence of bacterial vaginosis.

Authors:  Michelle C Meltzer; Renee A Desmond; Jane R Schwebke
Journal:  Sex Transm Dis       Date:  2008-06       Impact factor: 2.830

5.  The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosa.

Authors:  Colleen R Eade; Amy L Cole; Camila Diaz; Lisa C Rohan; Michael A Parniak; Preston Marx; Patrick M Tarwater; Phalguni Gupta; Alexander M Cole
Journal:  Am J Reprod Immunol       Date:  2012-11-20       Impact factor: 3.886

6.  Production and characterization of monoclonal antibodies to Mobiluncus species.

Authors:  M J Fohn; S A Lukehart; S L Hillier
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

7.  Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens.

Authors:  Ammar Algburi; Yingyue Zhang; Richard Weeks; Nicole Comito; Saskia Zehm; Juanita Pinto; Kathryn E Uhrich; Michael L Chikindas
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

8.  Tinidazole in the treatment of bacterial vaginosis.

Authors:  Nicola R Armstrong; Janet D Wilson
Journal:  Int J Womens Health       Date:  2010-08-09

9.  Microflora of the penile skin-lined neovagina of transsexual women.

Authors:  Steven Weyers; Hans Verstraelen; Jan Gerris; Stan Monstrey; Guido dos Santos Lopes Santiago; Bart Saerens; Ellen De Backer; Geert Claeys; Mario Vaneechoutte; Rita Verhelst
Journal:  BMC Microbiol       Date:  2009-05-20       Impact factor: 3.605

Review 10.  Advances in the Prevention of Infection-Related Preterm Birth.

Authors:  Ronald F Lamont
Journal:  Front Immunol       Date:  2015-11-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.